Loading...
Pipeline 2017-08-15T18:32:03+00:00

Ergon Pharmaceuticals aims at advancing a number of small organic molecules across a diverse spectrum of diseases. We are currently focusing on identifying candidate leads based on three distinct protein targets. The chart below depicts development plans as of June 2017.